Phibro Animal Health (NASDAQ:PAHC) Downgraded by StockNews.com to “Buy”

StockNews.com downgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a strong-buy rating to a buy rating in a research report released on Friday morning.

Several other equities analysts have also weighed in on the stock. Bank of America lifted their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. JPMorgan Chase & Co. initiated coverage on shares of Phibro Animal Health in a research report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective for the company. Morgan Stanley lifted their price target on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. Finally, Barclays increased their price target on Phibro Animal Health from $13.00 to $20.00 and gave the stock an “underweight” rating in a research report on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Stock Down 2.9 %

Phibro Animal Health stock opened at $21.05 on Friday. The business’s 50-day moving average price is $23.29 and its 200 day moving average price is $20.84. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The firm has a market cap of $852.59 million, a price-to-earnings ratio of 48.95, a price-to-earnings-growth ratio of 0.58 and a beta of 0.51. Phibro Animal Health has a 52 week low of $10.03 and a 52 week high of $25.98.

Phibro Animal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend was Wednesday, November 27th. Phibro Animal Health’s payout ratio is 111.63%.

Hedge Funds Weigh In On Phibro Animal Health

Hedge funds have recently made changes to their positions in the company. nVerses Capital LLC purchased a new position in shares of Phibro Animal Health in the third quarter worth about $70,000. Quantbot Technologies LP acquired a new stake in Phibro Animal Health in the 3rd quarter valued at about $70,000. China Universal Asset Management Co. Ltd. lifted its stake in Phibro Animal Health by 63.7% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after purchasing an additional 1,522 shares in the last quarter. CWM LLC boosted its holdings in shares of Phibro Animal Health by 190.8% during the 3rd quarter. CWM LLC now owns 6,363 shares of the company’s stock worth $143,000 after purchasing an additional 4,175 shares during the last quarter. Finally, Algert Global LLC purchased a new stake in shares of Phibro Animal Health in the second quarter valued at approximately $193,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.